Genetically engineered rodent models of mammary gland carcinogenesis: An overview

Authors
Citation
Pe. Blackshear, Genetically engineered rodent models of mammary gland carcinogenesis: An overview, TOX PATHOL, 29(1), 2001, pp. 105-116
Citations number
137
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICOLOGIC PATHOLOGY
ISSN journal
01926233 → ACNP
Volume
29
Issue
1
Year of publication
2001
Pages
105 - 116
Database
ISI
SICI code
0192-6233(200101/02)29:1<105:GERMOM>2.0.ZU;2-X
Abstract
Breast cancer is a multifactorial disease that develops as a result of inte ractions among genetic. environmental, and hormonal factors. Multiple genet ic derangements are believed to be involved in the pathogenesis of breast c ancer, including the inactivation of tumor suppressor genes and/or the disr egulation of proto-oncogenes. Age, hormones, and environmental factors furt her influence these genetic derangements. Spontaneous and chemically induce d animal models of breast cancer have been limited in their usefulness. The advent of targeted gene mutations has allowed for a more specific explorat ion of the pathogenesis of breast cancer by creating mouse models that mimi c single or multiple gene alterations found in human mammary tumors. The ge nes targeted in these models include mouse mammary tumor integration sites and genes that encode for growth regulators, signal transduction proteins, cell cycle proteins, and cell matrix proteinases. In this review. I summari ze tumor morphology and the relevance of each model to the pathogenesis and progression of human breast cancer. These models have great potential for elucidating the multistep process of mammary gland carcinogenesis and for c ontributing to the identification of novel therapeutic targets.